Stock EVAX EVAXION BIOTECH A/S
Add to a list
To use this feature you must be a member
Log inSign up

Company Evaxion Biotech A/S

Equities

EVAX

US29970R2040

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
4.14 USD -1.19% Intraday chart for Evaxion Biotech A/S +2.48% -39.62%
Apr. 17 Evaxion Announces Phase 2 Clinical Trial Update CI
Apr. 11 European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading MT

Business Summary

Evaxion Biotech A/S is a Denmark-based clinical-stage biotechnology company, which specializes in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases. The Company decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.

Number of employees: 49

Sales per Business

USD in Million2022Weight2023Weight Delta
Artificial Intelligence-Immunology Powered Vaccines
100.0 %
0 nan % 0 100.0 % -

Sales per region

USD in Million2022Weight2023Weight Delta
Denmark
100.0 %
0 nan % 0 100.0 % -

Managers

Managers TitleAgeSince
Andreas Mattsson FOU
 Founder - 08-08-10
Niels Møller FOU
 Founder 46 08-08-10
Christian Kanstrup CEO
 Chief Executive Officer 52 23-08-28
Jesper Nyegaard Nissen DFI
 Director of Finance/CFO 54 22-03-13
Birgitte Rono CTO
 Chief Tech/Sci/R&D Officer 47 17-08-31
Sabine Mølleskov IRC
 Investor Relations Contact - -

Members of the board

Members of the board TitleAgeSince
Roberto Prego Pineda BRD
 Director/Board Member 54 17-12-31
Lars Holtug BRD
 Director/Board Member 66 21-05-24
Marianne Søgaard CHM
 Chairman 56 17-12-31
Niels Møller FOU
 Founder 46 08-08-10

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 37,897,780 31,606,749 ( 83.40 %) 0 83.40 %

Shareholders

NameEquities%Valuation
LM Advisors LLC
0.7011 %
33,734 0.7011 % 107 949 $
Beacon Capital Management LLC (Tennessee)
0.1011 %
4,863 0.1011 % 15 562 $
Telemetry Investments LLC
0.0779 %
3,750 0.0779 % 12 000 $
Citadel Securities GP LLC
0.0512 %
2,463 0.0512 % 7 882 $
Renaissance Technologies LLC
0.0291 %
1,400 0.0291 % 4 480 $
Moloney Securities Asset Management LLC
0.0208 %
1,000 0.0208 % 3 200 $
JPMorgan Securities LLC
0.0187 %
900 0.0187 % 2 880 $
RhumbLine Advisers LP
0.006048 %
291 0.006048 % 931 $
Group One Trading LP
0.000811 %
39 0.000811 % 125 $
UBS Securities LLC
0.000582 %
28 0.000582 % 90 $
NameEquities%Valuation
Niels Møller
22.16 %
4,198,840 22.16 % 1 M $
Andreas Mattsson
21.49 %
4,071,961 21.49 % 1 M $
MERCK & CO., INC.
12.13 %
2,297,884 12.13 % 735 323 $
Roberto Prego Pineda
1.637 %
310,248 1.637 % 99 279 $
Marianne Søgaard
0.2198 %
41,652 0.2198 % 13 329 $
Steven Projan
0.1440 %
27,288 0.1440 % 8 732 $
Bo Karmark
0.0106 %
2,000 0.0106 % 640 $
Erik Deichmann Heegaard
0.000000 %
0 0.000000 % - $
Lars Holtug
0.000000 %
0 0.000000 % - $
Jesper Nyegaard Nissen
0.000000 %
0 0.000000 % - $

Company contact information

Evaxion Biotech A/S

Dr. Neergaards Vej 5F

2970, Hoersholm

+

http://www.evaxion-biotech.com
address Evaxion Biotech A/S(EVAX)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
4.14 USD
Average target price
11.75 USD
Spread / Average Target
+183.82%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
EVAXION BIOTECH A/S Stock Evaxion Biotech A/S
-39.62% 21.59M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+3.13% 43.43B
LONZA GROUP AG Stock Lonza Group AG
+48.88% 41.69B
MODERNA, INC. Stock Moderna, Inc.
+8.49% 41.31B
CELLTRION, INC. Stock Celltrion, Inc.
-10.82% 27.14B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.26% 25.28B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-23.69% 18.47B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
+1.58% 12.33B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+32.83% 12.59B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.63% 11.03B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. EVAX Stock
  4. Company Evaxion Biotech A/S